Public's Intended Uptake and Views on Organization of Esophageal Cancer Screening

Trial Title: Public's Intended Uptake and Views on Organization of Esophageal Cancer Screening

NCT ID: NCT05690958

Condition: Barrett Esophagus
Barrett Adenocarcinoma
Esophageal Adenocarcinoma

Conditions: Official terms:
Adenocarcinoma
Esophageal Neoplasms
Barrett Esophagus

Study type: Observational

Overall status: Recruiting

Study design:

Time perspective: Cross-Sectional

Intervention:

Intervention type: Other
Intervention name: Survey
Description: Filling in a survey

Summary: Rationale: Research on novel methods to screen for esophageal adenocarcinoma (EAC) has expanded. Insight into individuals' drivers and barriers to attend screening is essential to tailor a potential new screening policy to their preferences. Public preferences should also be considered on the organizational level to guarantee client-centered decision-making in the design of the screening process. Objective: This study will examine Dutch individuals' intended uptake of EAC screening, including factors that predict uptake, and their views on its organization. Study design: Cross-sectional population-based survey. Study population: Dutch individuals aged 45-75 years. The required sample size is 2088 and 8350 individuals will be invited based on an assumed participation rate of 25%. Methods: Eligible individuals will be selected from the Dutch population registry (BRP) using simple random sampling. Invitations will be sent by postal mail with participants being directed to a digital survey. Main study parameters/endpoints: The primary outcome of the study is the intended uptake of EAC screening (strong vs weak). Secondary study endpoints are the perceived need for consultation, perceived need for general education campaigns, acceptability of risk stratification scenarios, and acceptability of using health care resources for EAC screening. Nature and extent of the burden and risks associated with participation, benefit and group relatedness: Subjects will not directly benefit from participating in this study. Nonetheless, participating in this study is not associated with any healthcare risks and the burden for the subjects is very low. The survey has a low burdensome nature and will take approximately 15 to 20 minutes to complete. All data will be pseudonymized, refusal to fill out the survey or desire to withdraw from the study will not have any consequences for the invited subject.

Criteria for eligibility:

Study pop:
A sample will be drawn from the Dutch population registry, the 'Basisregistratie Personen' (BRP), using simple random sampling.

Sampling method: Probability Sample
Criteria:
Inclusion Criteria: - Aged 45 to 75 years Exclusion Criteria: - Previous diagnosis of EAC. - Unable to provide informed consent. - Unable to fill out the digital survey.

Gender: All

Gender based: Yes

Gender description: All genders are included in the study. We provide a non-binairy answer option for gender.

Minimum age: 45 Years

Maximum age: 75 Years

Healthy volunteers: Accepts Healthy Volunteers

Locations:

Facility:
Name: Radboudumc

Address:
City: Nijmegen
Zip: 6525GA
Country: Netherlands

Status: Recruiting

Contact:
Last name: jasmijn sijben

Phone: +31621193178
Email: jasmijn.sijben@radboudumc.nl

Start date: February 13, 2023

Completion date: July 1, 2023

Lead sponsor:
Agency: Radboud University Medical Center
Agency class: Other

Collaborator:
Agency: ZonMw: The Netherlands Organisation for Health Research and Development
Agency class: Other

Source: Radboud University Medical Center

Record processing date: ClinicalTrials.gov processed this data on November 12, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT05690958